Br J Cancer

1. KARAKULAK T, Moch H, von Mering C, Kahraman A, et al
   Switches in alternatively spliced isoforms impact protein and drug interactions in melanoma, ovarian cancer, and acute myeloid leukemia.
   Br J Cancer. 2026 Oct 3. doi: 10.1038/s41416-026-03638.
   

   >> Share

   
   

   
   Br J Dermatol

2. RAMAMURTHY SRINIVASAN M, de Berker D, Venables ZC, Levell NJ, et al
   The environmental burden of melanoma: a national stage-specific carbon footprint analysis.
   Br J Dermatol. 2026 Oct 8:ljag440. doi: 10.1093.
   

   >> Share

   
   
3. ADALSTEINSSON JA, Karadottir HL
   Surviving stage IV melanoma: the unfinished task of survivorship care.
   Br J Dermatol. 2026 Oct 5:ljag438. doi: 10.1093.
   

   >> Share

   
   

   
   J Am Acad Dermatol

4. GONZALEZ-CAO M, Puig S, Manzano JL, Berciano-Guerrero MA, et al
   Primary Melanoma Stage as a Predictor of Survival in Advanced Disease: Findings from the Spanish Melanoma Registry GEM1801.
   J Am Acad Dermatol. 2026 Oct 5:S0190-9622(26)03663.
   

   >> Share

   
   

   
   J Clin Oncol

5. HURD D, Davar D
   Reading Melanoma's Differentiation State to Settle the Combination Versus Sequencing Debate.
   J Clin Oncol. 2026 Oct 8:JCO2601593. doi: 10.1200/JCO-26-01593.
   

   >> Share

   
   

   
   Melanoma Res

6. JIANG C, Niu S, Li C, Liu A, et al
   Comprehensive analysis and external validation of a glycolysis-related gene signature as a prognostic index for skin cutaneous melanoma.
   Melanoma Res. 2026 Oct 6. doi: 10.1097/CMR.0000000000001143.
   

   >> Share

   
   

   
   PLoS One

7. LEI X, Liu W, Luo Z, Wu B, et al
   CD3-CSPG4 bispecific T cell engager: A novel platform for malignant melanoma therapy.
   PLoS One. 2026;21:e0357790.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share